GO:0004499 N,N-dimethylaniline monooxygenase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0004499 (N,N-dimethylaniline monooxygenase activity) catalyzes the NADPH- and O2-dependent N-oxidation of N,N-dimethylaniline to N,N-dimethylaniline N-oxide, a classic flavin-containing monooxygenase (FMO) reaction.
• The activity is widely used as a diagnostic probe for flavin-containing monooxygenase function in liver, lung, kidney and other tissues [2,3,7].
• Cytochrome P450 enzymes can also contribute to N,N-dimethylaniline N-oxygenation, sometimes via superoxide-dependent chemistry, so the activity is not exclusively FMO-driven [1,8].
• N,N-dimethylaniline is a model substrate for studying amine N-oxidation, N-demethylation and N-conjugation pathways in isolated hepatocytes and microsomes [1,4,5].
• The reaction requires NADPH, molecular oxygen and a flavin (FAD) cofactor, and produces the N-oxide plus NADP+ and water.
• CRISPR knockout, point-mutation, knock-in and overexpression models enable causal dissection of FMO and CYP contributions to this activity in cells and animals.
Description
N,N-dimethylaniline monooxygenase activity (GO:0004499) is a molecular function defined by the catalytic conversion of N,N-dimethylaniline to N,N-dimethylaniline N-oxide in the presence of NADPH, H+ and O2, yielding NADP+ and H2O. This activity is historically one of the most widely used probes for flavin-containing monooxygenase (FMO) enzymes, which are microsomal flavoproteins that oxidize a broad range of nucleophilic nitrogen- and sulfur-containing xenobiotics and drugs. Because N,N-dimethylaniline is a simple tertiary amine, its N-oxidation has served as a convenient readout for FMO-mediated metabolism in intact animals, isolated hepatocytes, and tissue microsomes [2,4,5]. Researchers value GO:0004499 because it provides a direct functional link between a defined enzymatic reaction and the broader biology of amine xenobiotic metabolism, drug clearance, and chemical toxicity [2,3]. The activity is not confined to a single enzyme family: cytochrome P450 isozymes can also N-demethylate or N-oxygenate N,N-dimethylaniline, and in some systems P450-dependent N-oxide formation involves superoxide [1,8]. This dual-enzyme context makes GO:0004499 an instructive model for dissecting overlapping oxidative pathways in drug metabolism [1,5,8]. In addition, the reaction has been detected in non-mammalian systems such as Trypanosoma cruzi, where a cytosolic flavin-containing enzyme converts N,N-dimethylaniline to its N-oxide, highlighting the evolutionary breadth of this chemistry. For biomedical researchers, GO:0004499 therefore represents both a practical assay endpoint and a mechanistically rich activity for studying flavin-dependent and P450-dependent oxidation in health and disease [2,7].
N,N-dimethylaniline monooxygenase activity At A Glance
| GO ID | GO:0004499 |
|---|---|
| GO term | N,N-dimethylaniline monooxygenase activity |
| Ontology | molecular_function |
| Synonym | flavin-containing monooxygenase activity; FMO activity; DMA oxidase activity; Ziegler's enzyme; dimethylaniline N-oxidase activity |
| Major function | NADPH- and O2-dependent N-oxidation of N,N-dimethylaniline to N,N-dimethylaniline N-oxide |
| Cofactor requirement | FAD (flavin adenine dinucleotide) and NADPH |
| Representative enzymes | Flavin-containing monooxygenases (FMOs) and certain cytochrome P450 isozymes |
| Tissue distribution | Liver, lung, kidney and other tissues in mammals |
| Assay readout | Formation of N,N-dimethylaniline N-oxide, often measured spectrophotometrically or by HPLC |
What Is GO:0004499?
GO:0004499 describes the catalysis of the reaction: N,N-dimethylaniline + NADPH + H+ + O2 = N,N-dimethylaniline N-oxide + NADP+ + H2O. In plain terms, it is the enzyme activity that attaches an oxygen atom to the nitrogen of N,N-dimethylaniline, using NADPH as the electron donor and molecular oxygen as the oxygen source, and releasing the N-oxide product together with NADP+ and water. The activity is synonymous with flavin-containing monooxygenase (FMO) activity, DMA oxidase, dimethylaniline N-oxidase, and Ziegler's enzyme, reflecting its historical association with microsomal flavin-dependent amine oxidation.
Why Is N,N-dimethylaniline monooxygenase activity Important in Cell Biology?
GO:0004499 is important because it defines a central reaction in the oxidative metabolism of tertiary amines and provides a functional handle on flavin-containing monooxygenase biology, which influences drug disposition, xenobiotic detoxification, and chemical toxicity. Because N,N-dimethylaniline N-oxidation can be catalyzed by both FMOs and cytochrome P450 enzymes, the activity is also a valuable experimental system for resolving overlapping metabolic routes and for understanding how NADPH-dependent oxidation is partitioned between enzyme families [1,5,8]. Its measurement in intact animals, isolated hepatocytes, and tissue fractions has made it a long-standing benchmark for comparing species, tissues, and disease states in pharmacology and toxicology [2,3,4,7].
• Provides a direct functional assay for flavin-containing monooxygenase (FMO) enzymes in cells and tissues.
• Serves as a model reaction for studying tertiary amine N-oxidation, a common route of drug and xenobiotic metabolism [2,5].
• Helps distinguish FMO-mediated oxidation from cytochrome P450-mediated N-demethylation and N-oxygenation [1,8].
• Enables comparative studies of xenobiotic metabolism across species and tissues such as liver, lung and kidney [3,5,7].
• Supports investigation of NADPH-dependent oxidative pathways and superoxide involvement in N-oxide formation.
• Can be used to characterize N-conjugate formation and downstream metabolite handling in isolated hepatocytes.
• Extends to non-mammalian systems, as shown by a cytosolic flavin-containing enzyme in Trypanosoma cruzi.
• Informs drug metabolism and toxicity predictions where amine-containing compounds are developed as therapeutics.
• Offers a defined enzymatic endpoint for CRISPR-based perturbation of candidate FMO and CYP genes.
• Links molecular enzymology to whole-animal pharmacokinetics through intact-animal activity assessment.
Molecular Mechanism of N,N-dimethylaniline monooxygenase activity
Substrate binding and the N-oxidation reaction
In simple terms: The enzyme grabs N,N-dimethylaniline and adds an oxygen atom to its nitrogen.
The defining chemistry of GO:0004499 is the conversion of N,N-dimethylaniline to N,N-dimethylaniline N-oxide, a reaction that requires NADPH, H+ and O2 and yields NADP+ and H2O. This N-oxidation is the classic readout for flavin-containing monooxygenase activity, and it has been measured in intact animals as an index of FMO function. The same substrate can also undergo oxidative N-demethylation, a reaction catalyzed by purified cytochrome P-450 isozymes, showing that N,N-dimethylaniline is a branch-point substrate for multiple oxidative enzymes.
Flavin-dependent catalysis by FMO enzymes
In simple terms: A flavin cofactor inside the enzyme uses NADPH and oxygen to oxidize the substrate.
Flavin-containing monooxygenases are the enzymes most closely associated with GO:0004499, and their activity is routinely assessed using N,N-dimethylaniline as a probe substrate. A cytosolic flavin-containing enzyme from Trypanosoma cruzi converts N,N-dimethylaniline to N,N-dimethylaniline N-oxide, demonstrating that flavin-dependent N-oxidation of this substrate is not restricted to mammals. In rat kidney, catalytic activity and immunohistochemical localization of flavin-containing monooxygenase have been characterized, supporting a tissue-level role for this activity.
Cytochrome P450 contribution and superoxide involvement
In simple terms: Some P450 enzymes can also make the N-oxide, sometimes using superoxide.
Metabolic N-oxide formation from N,N-dimethylaniline by rabbit-liver microsomal cytochrome P-4502B4 involves superoxide in the NADPH-dependent N-oxygenation reaction. Comparative studies on the N-oxidation of aniline and N,N-dimethylaniline by rabbit liver microsomes further illustrate how microsomal systems handle these amine substrates. Purified cytochrome P-450 isozymes can also oxidatively N-demethylate N,N-dimethylaniline, indicating that P450 enzymes contribute to the overall metabolic fate of this compound.
Tissue context and cellular metabolism
In simple terms: Different organs and cell systems process N,N-dimethylaniline in different ways.
N-oxidation of N,N-dimethylaniline has been studied in rabbit and rat lung, showing that pulmonary tissue can carry out this reaction. The metabolism of N,N-dimethylaniline by isolated rat hepatocytes leads to identification of a novel N-conjugate, indicating that N-oxidation is part of a broader metabolic network in liver cells. Flavin-containing monooxygenase activity in intact animals provides a whole-organism context for interpreting these tissue-level findings.
Cofactors and co-substrates
In simple terms: The reaction needs NADPH, oxygen and a flavin to proceed.
The GO definition specifies NADPH, H+ and O2 as co-substrates and NADP+ and H2O as co-products, consistent with the flavin-containing monooxygenase mechanism. The involvement of superoxide in P4502B4-catalyzed N-oxide formation highlights that oxygen activation chemistry can vary between enzyme systems. These cofactor requirements make the activity sensitive to cellular redox status and NADPH supply.
Key Genes Involved in GO:0004499 N,N-dimethylaniline monooxygenase activity
The genes and proteins most relevant to GO:0004499 include flavin-containing monooxygenases (FMOs) and cytochrome P450 enzymes that have been experimentally linked to N,N-dimethylaniline N-oxidation, N-demethylation or N-conjugation.
| Gene | Major Role | Research Relevance |
|---|---|---|
| FMO1 | Flavin-containing monooxygenase that can catalyze N-oxidation of tertiary amines | Model FMO for studying GO:0004499 in vitro and in cells |
| FMO2 | Flavin-containing monooxygenase expressed in lung and other tissues | Relevant to pulmonary N-oxidation of N,N-dimethylaniline |
| FMO3 | Major hepatic flavin-containing monooxygenase | Central to drug and xenobiotic N-oxidation studies |
| FMO4 | Flavin-containing monooxygenase family member | Candidate for comparative FMO activity studies |
| FMO5 | Flavin-containing monooxygenase family member | Potential contributor to amine oxidation pathways |
| CYP2B4 | Cytochrome P450 isozyme that forms N-oxide from N,N-dimethylaniline | Mechanistic model for superoxide-dependent N-oxygenation |
| CYP2B6 | Human cytochrome P450 involved in amine drug metabolism | Comparative P450 vs FMO N-oxidation studies |
| CYP3A4 | Major human drug-metabolizing P450 | Context for overlapping oxidative metabolism of amines |
| CYP1A2 | Cytochrome P450 isozyme active toward aromatic amines | Model for N-demethylation and N-oxidation comparisons |
| CYP2D6 | Polymorphic drug-metabolizing P450 | Candidate for interindividual variability in amine oxidation |
| CYP2C9 | Drug-metabolizing P450 isozyme | Potential background enzyme in N,N-dimethylaniline metabolism |
| CYP2E1 | P450 isozyme involved in small-molecule oxidation | Relevant to oxidative stress-linked N-oxygenation |
| FMO (Trypanosoma cruzi cytosolic enzyme) | Cytosolic flavin-containing enzyme that N-oxidizes N,N-dimethylaniline | Non-mammalian model for GO:0004499 |
| Rat kidney FMO | Flavin-containing monooxygenase localized in kidney | Tissue-specific activity and localization studies |
| Rabbit liver microsomal FMO | Microsomal flavin-containing monooxygenase | Classic source for N,N-dimethylaniline N-oxidation assays |
| Rat hepatocyte conjugation enzymes | Enzymes forming N-conjugates of N,N-dimethylaniline metabolites | Downstream metabolite handling studies |
| NADPH-regenerating enzymes | Maintain NADPH supply for monooxygenase reactions | Cofactor supply and redox context for GO:0004499 |
How Is N,N-dimethylaniline monooxygenase activity Regulated?
The activity described by GO:0004499 is regulated at multiple levels, including enzyme expression, cofactor availability and competing metabolic routes. Flavin-containing monooxygenase activity can be assessed in intact animals, indicating that whole-organism physiology influences the measured N-oxidation capacity. Tissue-specific expression patterns, such as the localization of flavin-containing monooxygenase in rat kidney, suggest that regulation is partly spatial and cell-type dependent. Because cytochrome P450 enzymes can also contribute to N,N-dimethylaniline N-oxide formation, including superoxide-dependent chemistry, the balance between FMO and P450 pathways is an additional regulatory layer [1,8]. NADPH supply and oxygen availability are also expected to modulate the reaction, given the co-substrate requirements in the GO definition.
N,N-dimethylaniline monooxygenase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| FMO3 | Drug metabolism and amine oxidation capacity | FMO3 knockout and overexpression cell lines |
| CYP2B4 | Superoxide-dependent N-oxygenation and oxidative stress | CYP2B4 point-mutation and knockout models |
| FMO1 | Tissue-specific xenobiotic N-oxidation | FMO1 knockout and tagged knock-in cells |
| CYP2B6 | Interindividual variability in amine drug metabolism | CYP2B6 polymorphism knock-in models |
| Trypanosoma cruzi cytosolic FMO | Parasite amine metabolism | Parasite enzyme overexpression in host cells |
Xenobiotic metabolism and drug response
GO:0004499 is directly relevant to how the body handles amine-containing xenobiotics and drugs, because flavin-containing monooxygenases and cytochrome P450 enzymes that catalyze this reaction are major determinants of metabolic clearance. Interindividual differences in these enzymes can influence drug exposure and toxicity, making the activity a useful probe in pharmacology [1,2].
Chemical toxicity and oxidative stress
The involvement of superoxide in P4502B4-catalyzed N-oxide formation links GO:0004499 to oxidative stress biology, where reactive oxygen species can contribute to metabolic activation and toxicity. Studying this activity helps clarify when N-oxidation is a detoxification route versus a source of reactive intermediates.
Tissue-specific metabolism in liver, lung and kidney
N,N-dimethylaniline N-oxidation has been documented in lung and kidney as well as liver, indicating that GO:0004499 contributes to local xenobiotic processing in multiple organs [3,7]. Isolated hepatocyte studies further show that N,N-dimethylaniline undergoes additional conjugation, connecting this activity to broader hepatic metabolic networks.
Comparative and infectious disease contexts
A cytosolic flavin-containing enzyme from Trypanosoma cruzi converts N,N-dimethylaniline to its N-oxide, showing that GO:0004499-like chemistry exists in protozoan parasites and may be relevant to host-pathogen metabolic interactions. This comparative angle can inform research on parasite-specific oxidation pathways.
From N,N-dimethylaniline monooxygenase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does FMO3 loss reduce N,N-dimethylaniline N-oxidation? | FMO3 knockout cell line |
| Does a specific FMO variant alter catalytic efficiency? | FMO point-mutation knock-in |
| Can a tagged FMO be used to measure enzyme localization? | Tagged knock-in (e.g., FLAG or GFP) |
| Does FMO overexpression increase N-oxide formation? | FMO overexpression cell line |
| Does CYP2B4 contribute to superoxide-dependent N-oxidation? | CYP2B4 knockout and point-mutation models |
| How does hepatocyte metabolism route N,N-dimethylaniline? | Primary hepatocyte or hepatocyte-like cell models |
How to Study the N,N-dimethylaniline monooxygenase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| N-oxide formation assay | Conversion of N,N-dimethylaniline to its N-oxide | FMO activity measurement in tissues and cells |
| Microsomal incubation | Enzyme-catalyzed N-oxidation in native membranes | Liver and lung metabolism studies [3,5] |
| Hepatocyte metabolite profiling | N-oxide and conjugate formation | Cellular metabolic pathway analysis |
| Purified enzyme reconstitution | Direct catalytic activity of a specific enzyme | Mechanistic studies of FMO and P450 [1,6] |
| Immunohistochemistry | Tissue localization of FMO protein | Kidney and other tissue expression mapping |
| Superoxide detection | Reactive oxygen involvement in N-oxygenation | P4502B4 mechanistic studies |
| Intact-animal activity assessment | Whole-organism FMO activity | In vivo pharmacology and toxicology |
| Comparative species assay | Species differences in N-oxidation | Cross-species metabolism studies |
Enzyme activity assays with N,N-dimethylaniline
The most direct way to study GO:0004499 is to measure N,N-dimethylaniline N-oxide formation in microsomes, tissue fractions or intact animals, as established for flavin-containing monooxygenase activity. Such assays can be applied to liver, lung and kidney preparations to compare tissue-specific activity [3,5,7].
Metabolite profiling in hepatocytes
Isolated rat hepatocytes metabolize N,N-dimethylaniline and produce a novel N-conjugate, making hepatocyte systems valuable for tracking the fate of the N-oxide and related metabolites. Metabolite profiling by chromatography or mass spectrometry can resolve N-oxidation from N-demethylation and conjugation pathways [1,4].
Enzyme purification and reconstitution
Purified cytochrome P-450 isozymes and flavin-containing enzymes can be reconstituted with NADPH and oxygen to study the mechanism of N,N-dimethylaniline oxidation in isolation [1,6]. This approach helps attribute activity to specific enzymes and reveals superoxide involvement in some P450 reactions.
Immunolocalization and expression analysis
Immunohistochemical localization of flavin-containing monooxygenase in rat kidney demonstrates how protein expression patterns can be linked to measured catalytic activity. Combining activity assays with expression analysis helps interpret tissue-specific contributions to GO:0004499.
How CRISPR Can Be Used to Study GO:0004499 N,N-dimethylaniline monooxygenase activity
Knockout
CRISPR knockout of candidate FMO or CYP genes can test whether a specific enzyme is required for N,N-dimethylaniline N-oxidation in a given cell type. For example, knocking out FMO3 or CYP2B4 and measuring residual N-oxide formation can separate FMO-dependent from P450-dependent contributions [2,8].
Point Mutation
Point-mutation models can interrogate catalytic residues or regulatory sites in FMO and CYP enzymes, helping determine which amino acids are required for N-oxidation activity. Such models are particularly useful for testing hypotheses about superoxide-dependent N-oxygenation by P4502B4.
Knock-in
Knock-in of tagged or variant enzymes allows precise measurement of protein localization, stability and activity in the context of GO:0004499. Tagged FMO knock-ins can be used to correlate enzyme abundance with N-oxide formation in different tissues [2,7].
Overexpression
Overexpression of FMO or CYP enzymes can amplify N,N-dimethylaniline N-oxidation and reveal rate-limiting steps or substrate saturation effects. Overexpression models are also useful for comparing the catalytic efficiency of different enzyme isoforms [1,2].
How EDITGENE Supports N,N-dimethylaniline monooxygenase activity Research
Researchers studying N,N-dimethylaniline monooxygenase activity-related genes often need to determine whether a candidate gene is causally involved in N-oxidation, whether a specific variant alters catalytic efficiency, or whether enzyme abundance correlates with activity in a given tissue. EDITGENE provides CRISPR-based cell models and screening services designed to answer these questions with reproducible, publication-ready data.
Contact EDITGENE today to design your custom CRISPR model for N,N-dimethylaniline monooxygenase activity research.
Frequently Asked Questions About N,N-dimethylaniline monooxygenase activity
What is N,N-dimethylaniline monooxygenase activity?
It is the enzyme activity defined by GO:0004499 that converts N,N-dimethylaniline to N,N-dimethylaniline N-oxide using NADPH, H+ and O2, releasing NADP+ and H2O.
What genes are involved in N,N-dimethylaniline monooxygenase activity?
Flavin-containing monooxygenase (FMO) genes and certain cytochrome P450 genes, such as CYP2B4, have been linked to this activity [1,2,8].
What is the GO ID for N,N-dimethylaniline monooxygenase activity?
The GO ID is GO:0004499.
Which enzymes catalyze N,N-dimethylaniline N-oxidation?
Flavin-containing monooxygenases are the classic enzymes, but cytochrome P450 isozymes can also contribute, sometimes via superoxide-dependent chemistry [1,2,8].
What cofactors are required for GO:0004499?
The reaction requires NADPH, H+ and O2, and flavin-containing monooxygenases use an FAD cofactor.
How is N,N-dimethylaniline monooxygenase activity measured?
It is commonly measured by detecting N,N-dimethylaniline N-oxide formation in microsomes, tissue fractions, hepatocytes or intact animals [2,3,4].
Is N,N-dimethylaniline N-oxidation tissue-specific?
Yes, activity has been documented in liver, lung and kidney, with tissue-specific expression of flavin-containing monooxygenases [3,5,7].
Can cytochrome P450 enzymes form N,N-dimethylaniline N-oxide?
Yes, rabbit-liver microsomal cytochrome P-4502B4 can form the N-oxide in an NADPH-dependent reaction involving superoxide.
What is the relationship between GO:0004499 and drug metabolism?
The activity is a model for tertiary amine N-oxidation, a common route of drug and xenobiotic metabolism mediated by FMOs and P450s [1,2].
How can CRISPR help study N,N-dimethylaniline monooxygenase activity?
CRISPR knockout, point-mutation, knock-in and overexpression models can test which genes and residues are required for N-oxide formation [2,8].
Conclusion
GO:0004499 (N,N-dimethylaniline monooxygenase activity) defines a classic NADPH- and O2-dependent N-oxidation reaction that has been used for decades to probe flavin-containing monooxygenase biology and overlapping cytochrome P450 chemistry [1,2,8]. Its measurement across liver, lung, kidney and intact animals provides a practical link between molecular enzymology and whole-organism xenobiotic metabolism [2,3,7]. With CRISPR-based knockout, point-mutation, knock-in and overexpression models, researchers can now causally dissect the genes and residues that govern this activity in health and disease [2,8].
References
- 1. Pandey RN et al.. 1989. Oxidative N-demethylation of N,N-dimethylaniline by purified isozymes of cytochrome P-450.. Biochem Pharmacol 38(13):2181-5 PMID: 2500128
- 2. Damani LA et al.. 1996. The assessment of flavin-containing monooxygenase activity in intact animals.. Drug Metabol Drug Interact 13(1):1-28 PMID: 8902428
- 3. Ohmiya Y et al.. 1983. N-oxidation of N,N-dimethylaniline in the rabbit and rat lung.. Biochem Pharmacol 32(7):1281-5 PMID: 6847718
- 4. Sherratt AJ et al.. 1989. The metabolism of N,N-dimethylaniline by isolated rat hepatocytes: identification of a novel N-conjugate.. Xenobiotica 19(4):379-88 PMID: 2750202
- 5. Hlavica P et al.. 1976. Comparative studies on the N-oxidation of aniline and N,N-dimethylaniline by rabbit liver microsomes.. Xenobiotica 6(11):679-89 PMID: 11613
- 6. Agosin M et al.. 1987. Conversion of N,N-dimethylaniline to N,N-dimethylaniline-N-oxide by a cytosolic flavin-containing enzyme from Trypanosoma cruzi.. Drug Metab Dispos 15(2):200-3 PMID: 2882978
- 7. Bhamre S et al.. 1993. Catalytic activity and immunohistochemical localization of flavin-containing monooxygenase in rat kidney.. Life Sci 52(20):1601-7 PMID: 8483388
- 8. Hlavica P et al.. 1993. Metabolic N-oxide formation by rabbit-liver microsomal cytochrome P-4502B4: involvement of superoxide in the NADPH-dependent N-oxygenation of N,N-dimethylaniline.. Biochim Biophys Acta 1158(1):83-90 PMID: 8394743
